Clinical Significance of Arginine Signaling in Patients with Cervical Cancer Receiving Cisplatin Chemoradiation Therapy

被引:0
|
作者
Chen, H. H. W. [1 ]
Lee, W. Y. [2 ]
Lai, Y. H. [1 ]
机构
[1] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Radiat Oncol, Tainan, Taiwan
[2] Chi Mei Med Ctr, Dept Pathol, Tainan, Taiwan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3106
引用
收藏
页码:E506 / E506
页数:1
相关论文
共 50 条
  • [1] Prognostic Significance of p16 in Patients with Cervical Cancer Receiving Definitive Chemoradiation
    Hassanzadeh, Comron
    Srivastava, Amar
    Markovina, Stephanie
    Schwarz, Julie
    Grigsby, Perry
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 103 (05): : E33 - E33
  • [2] Cisplatin Induced SIADH in Patients Receiving Concurrent Chemoradiation Therapy: A Rare Clinical Observation
    Praneetha, Chevireddy
    Subramanian, Bala Venkat
    Deepthi, Govindu Vaishnavi
    Basha, Pettikota Masthan
    Das, Pranabandhu
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2018, 12 (11) : XD1 - XD2
  • [3] Chemoradiation therapy for cervical cancer: Toxicity of concurrent weekly cisplatin
    Ikushima H.
    Osaki K.
    Furutani S.
    Yamashita K.
    Kawanaka T.
    Kishida Y.
    Iwamoto S.
    Takegawa Y.
    Kudoh T.
    Nishitani H.
    Radiation Medicine, 2006, 24 (2): : 115 - 121
  • [4] ANAEMIC SYNDROME CORRECTION IN PATIENTS RECEIVING CHEMORADIATION THERAPY WITH EPREX FOR UTERINE CERVICAL CANCER
    Fagim, M.
    Dina, S.
    Svetlana, D.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S308 - S308
  • [5] Significance of HIV status in cervical cancer patients receiving curative chemoradiation therapy, definitive radiation alone, or palliative radiation in Botswana
    Meghani, Kinza
    Puri, Priya
    Bazzett-Matabele, Lisa
    Vuylsteke, Peter
    Luckett, Rebecca
    Monare, Barati
    Chiyapo, Sebathu
    Ketlametswe, Rebecca
    Ralefala, Tlotlo B.
    Bvochora-Nsingo, Memory
    Zetola, Nicola
    Ramogola-Masire, Doreen
    Grover, Surbhi
    CANCER, 2024, 130 (14) : 2462 - 2471
  • [6] Epigenetic therapy and cisplatin chemoradiation in FIGO Stage IIIB cervical cancer
    Candelaria, M.
    Cetina, L.
    Perez-Cardenas, E.
    de la Cruz-Hernandez, E.
    Gonzalez-Fierro, A.
    Trejo-Becerril, C.
    Taja-Chayeb, L.
    Chanona, J.
    Arias, D.
    Duenas-Gonzalez, A.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2010, 31 (04) : 386 - 391
  • [7] Prognostic Utility of Pretreatment Hematologic Parameters in Patients Receiving Definitive Chemoradiation Therapy for Cervical Cancer
    Onal, C.
    Guler, O. C.
    Yildirim, B. Akkus
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S51 - S51
  • [8] Prognostic Significance of Lymphadenectomy in Esophageal Cancer Patients Receiving Neoadjuvant Chemoradiation
    Vijapura, C.
    Shridhar, R.
    Weber, J.
    Hoffe, S.
    Alhamanna, K.
    Deneve, J.
    Barthel, J.
    Karl, R.
    Meredith, K.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S133 - S133
  • [9] CLINICAL USEFULNESS OF PREDICTED CREATININE CLEARANCE IN CANCER-PATIENTS RECEIVING CISPLATIN THERAPY
    IBRAHIM, EM
    ALMOHAYA, SA
    ALIDRISSI, HY
    ALJASSER, HH
    ALFEHAID, SA
    IBRAHIM, FAS
    ANNALS OF SAUDI MEDICINE, 1989, 9 (05) : 439 - 442
  • [10] The Incidence of Cisplatin-induced Hypomagnesemia in Cervical Cancer Patients Receiving Cisplatin Alone
    Yamamoto, Yoshihiro
    Watanabe, Kazushi
    Matsushita, Hiroshi
    Tsukiyama, Ikuto
    Matsuura, Katsuhiko
    Wakatsuki, Akihiko
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2017, 137 (01): : 79 - 82